Afatinib Active Not Recruiting Phase 2 Trials for Stage IV Squamous Cell Carcinoma of the Hypopharynx / Salivary Gland Squamous Cell Carcinoma / Stage III Salivary Gland Cancer / Stage IVA Squamous Cell Carcinoma of the Lip and Oral Cavity / Stage IVB Salivary Gland Cancer / Stage IVC Squamous Cell Carcinoma of the Larynx / Stage III Verrucous Carcinoma of the Oral Cavity / Stage IVA Verrucous Carcinoma of the Larynx / Tongue Cancer / Stage IVA Squamous Cell Carcinoma of the Larynx / Stage IVB Verrucous Carcinoma of the Oral Cavity / Stage III Verrucous Carcinoma of the Larynx / Stage III Squamous Cell Carcinoma of the Larynx / Stage IVC Squamous Cell Carcinoma of the Lip and Oral Cavity / Stage IVB Squamous Cell Carcinoma of the Larynx / Stage IV Squamous Cell Carcinoma of the Larynx / Stage IVA Salivary Gland Cancer / Stage IVC Verrucous Carcinoma of the Oral Cavity / Stage III Squamous Cell Carcinoma of the Lip and Oral Cavity / Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma / Stage IVB Verrucous Carcinoma of the Larynx / Stage IVB Squamous Cell Carcinoma of the Lip and Oral Cavity / Stage IVC Squamous Cell Carcinoma of the Oropharynx / Stage IVC Verrucous Carcinoma of the Larynx / Stage III Squamous Cell Carcinoma of the Hypopharynx / Stage IVA Squamous Cell Carcinoma of the Oropharynx / Head and Neck Squamous Cell Carcinoma (HNSCC) / Stage III Squamous Cell Carcinoma of the Oropharynx / Stage IVA Verrucous Carcinoma of the Oral Cavity / Stage IVC Salivary Gland Cancer / Stage IVB Squamous Cell Carcinoma of the Oropharynx Treatment

IndicationsStatusPurposePhase
Active Not RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01824823Afatinib After Chemoradiation and Surgery in Treating Patients With Stage III-IV Squamous Cell Carcinoma of the Head and Neck at High-Risk of Recurrence